Index of reports
> Cases with Pulmonary Embolism (13)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cinryze (Human C1-Esterase Inhibitor) where reactions include pulmonary embolism. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Cinryze side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: female, weighing 98.4 kg (216.5 pounds)
Reactions: Abdominal Pain, Nausea, Hypotension, Bundle Branch Block Right, Pulmonary Embolism, Convulsion, Syncope, Abdominal Distension, Cardiac Arrest, Oxygen Saturation Decreased
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Cinryze
Start date: 2012-07-09
End date: 2012-07-09
Cinryze
Start date: 2011-11-07
End date: 2011-11-07
Cinryze
Start date: 2012-07-09
End date: 2012-07-09
Cinryze
Start date: 2010-11-27
End date: 2010-11-27
Cinryze
Start date: 2010-11-27
End date: 2010-11-27
Cinryze
Start date: 2012-02-06
End date: 2012-02-06
Cinryze
Start date: 2011-08-24
End date: 2011-08-24
Cinryze
Start date: 2012-02-06
End date: 2012-02-06
Cinryze
Start date: 2011-11-07
End date: 2011-11-07
Cinryze
Start date: 2012-06-28
End date: 2012-06-28
Cinryze
Start date: 2012-02-13
End date: 2012-02-13
Cinryze
Start date: 2011-08-24
End date: 2011-08-24
Cinryze
Start date: 2012-02-13
End date: 2012-02-13
Cinryze
Start date: 2009-10-01
End date: 2009-10-01
Cinryze
Start date: 2012-06-28
End date: 2012-06-28
Cinryze
Start date: 2010-11-27
End date: 2010-11-27
Cinryze
Indication: Hereditary Angioedema
Start date: 2012-07-09
End date: 2012-07-09
Cinryze
Indication: Abdominal Distension
Start date: 2012-02-06
End date: 2012-02-06
Cinryze
Indication: Nausea
Start date: 2010-11-27
End date: 2010-11-27
Cinryze
Start date: 2012-06-28
End date: 2012-06-28
Cinryze
Start date: 2011-08-24
End date: 2011-08-24
Cinryze
Start date: 2012-02-06
End date: 2012-02-06
Cinryze
Start date: 2009-10-01
End date: 2009-10-01
Cinryze
Start date: 2012-02-13
End date: 2012-02-13
Cinryze
Start date: 2011-11-07
End date: 2011-11-07
Cinryze
Start date: 2012-02-13
End date: 2012-02-13
Cinryze
Start date: 2012-07-09
End date: 2012-07-09
Cinryze
Start date: 2009-10-01
End date: 2009-10-01
Cinryze
Start date: 2011-08-24
End date: 2011-08-24
Cinryze
Indication: Pain
Start date: 2009-10-01
End date: 2009-10-01
Cinryze
Start date: 2011-11-07
End date: 2011-11-07
Cinryze
Start date: 2012-06-28
End date: 2012-06-28
Nuvaring
Indication: Contraception
Start date: 2011-08-27
End date: 2011-09-24
Ortho TRI-Cyclen LO
Administration route: Oral
Indication: Contraception
Start date: 2012-06-21
Other drugs received by patient: Melatonin; Epipen; Fexofenadine; Fexofenadine; Metoprolol Tartrate; Nortriptyline; Clonazepam; Prilosec; Citalopram Hydrobromide; Remeron
Possible Cinryze side effects in female
Reported by a individual with unspecified qualification from United States on 2012-08-21
Patient: female, weighing 98.5 kg (216.7 pounds)
Reactions: Off Label Use, Syncope, Acute Sinusitis, Cerebral Infarction, Hereditary Angioedema, Pulmonary Embolism, Depression, Cardiac Arrest, Convulsion
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Cinryze
Start date: 2011-11-07
End date: 2011-11-07
Cinryze
Indication: Hereditary Angioedema
Start date: 2009-10-01
End date: 2009-10-01
Cinryze
Start date: 2012-07-09
Cinryze
Start date: 2011-08-24
End date: 2011-08-24
Cinryze
Start date: 2012-02-06
End date: 2012-02-06
Cinryze
Start date: 2012-02-13
End date: 2012-02-13
Cinryze
Start date: 2012-06-28
End date: 2012-06-28
Cinryze
Start date: 2010-11-27
End date: 2010-11-27
Nuvaring
Indication: Contraception
Start date: 2011-09-03
End date: 2011-09-24
Ortho TRI-Cyclen LO
Indication: Contraception
Other drugs received by patient: Citalopram Hydrobromide; Epipen; Metoprolol Tartrate; Melatonin; Clonazepam; Fexofenadine; Remeron; Nortriptyline; Prilosec
Possible Cinryze side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient: female
Reactions: Angioedema, Nausea, Pain, Pulmonary Embolism, Bundle Branch Block Right, Cerebrovascular Accident, Convulsion, Syncope, Abdominal Distension, Hemiplegia, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cinryze
Indication: Hereditary Angioedema
Start date: 2012-07-09
Cinryze
Dosage: 1000 units
Start date: 2009-10-01
Cinryze
Start date: 2011-08-01
Norgestimate and Ethinyl Estradiol
Indication: Contraception
Other drugs received by patient: Metoprolol Tartrate; Fexofenadine; Nortriptyline HCL; Klonopin; Omeprazole; Celexa
Possible Cinryze side effects in female
Reported by a physician from United States on 2012-07-30
Patient: female
Reactions: Off Label Use, Syncope, Pulmonary Embolism, Hereditary Angioedema, Cerebrovascular Accident, Cardiac Arrest, Convulsion
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cinryze
Indication: Hereditary Angioedema
Start date: 2009-10-01
Ortho TRI-Cyclen LO
Dosage: unknown
Indication: Contraception
Other drugs received by patient: Metoprolol Tartrate; Nortriptyline HCL; Omeprazole; Fexofenadine; Klonopin; Celexa
Possible Cinryze side effects in 11 year old male
Reported by a pharmacist from United States on 2012-06-20
Patient: 11 year old male, weighing 66.0 kg (145.2 pounds)
Reactions: Thrombosis, Off Label Use, Foot Fracture, Pulmonary Embolism, Osteomyelitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cinryze
Other drugs received by patient: Adderall XR 10
Possible Cinryze side effects in 11 year old male
Reported by a pharmacist from United States on 2012-06-18
Patient: 11 year old male, weighing 66.0 kg (145.2 pounds)
Reactions: Foot Fracture, Thrombosis, Off Label Use, Pulmonary Embolism, Osteomyelitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adderall XR 10
Indication: Product Used FOR Unknown Indication
Cinryze
Dosage: unknown
Indication: Hereditary Angioedema
Start date: 2009-12-01
Possible Cinryze side effects in 30 year old female
Reported by a physician from United States on 2012-05-25
Patient: 30 year old female, weighing 103.5 kg (227.7 pounds)
Reactions: Device Related Sepsis, Hereditary Angioedema, Pulmonary Embolism, Drug Interaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cinryze
Start date: 2012-01-01
Cinryze
Indication: Hereditary Angioedema
Start date: 2012-02-10
End date: 2012-03-18
Cinryze
Start date: 2012-03-21
End date: 2012-03-21
Kalbitor
Start date: 2012-01-27
End date: 2012-01-27
Kalbitor
Indication: Hereditary Angioedema
Start date: 2012-01-26
End date: 2012-01-26
Kalbitor
Start date: 2012-02-01
End date: 2012-02-01
Kalbitor
Start date: 2012-03-20
End date: 2012-03-20
Other drugs received by patient: Coreg; Lexapro; Insulin; Allergy Medication
Possible Cinryze side effects in female
Reported by a physician from United States on 2012-05-14
Patient: female, weighing 103.5 kg (227.7 pounds)
Reactions: Angioedema, Sepsis, Pulmonary Embolism, Hereditary Angioedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cinryze
Indication: Hereditary Angioedema
Start date: 2012-02-10
End date: 2012-03-22
Kalbitor
Dosage: unknown
Indication: Hereditary Angioedema
Start date: 2012-01-26
Unspecified Allergy Injection
Dosage: unknown
Indication: Hypersensitivity
Start date: 2012-03-20
End date: 2012-03-20
Other drugs received by patient: Coreg; Apidra; Lexapro
Possible Cinryze side effects in female
Reported by a physician from United States on 2012-04-19
Patient: female, weighing 103.5 kg (227.7 pounds)
Reactions: Angioedema, Sepsis, Pulmonary Embolism, Hereditary Angioedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cinryze
Indication: Hereditary Angioedema
Start date: 2012-02-10
End date: 2012-03-18
Kalbitor
Dosage: unknown
Indication: Hereditary Angioedema
Start date: 2012-01-26
Unspecified Allergy Injection
Dosage: unknown
Indication: Hypersensitivity
Other drugs received by patient: Lexapro; Coreg; Apidra
Possible Cinryze side effects in 30 year old female
Reported by a physician from United States on 2012-04-04
Patient: 30 year old female, weighing 103.5 kg (227.7 pounds)
Reactions: Drug Interaction, Hereditary Angioedema, Pulmonary Embolism
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cinryze
Indication: Hereditary Angioedema
End date: 2012-03-18
Kalbitor
Indication: Hereditary Angioedema
Start date: 2012-01-26
End date: 2012-01-26
Kalbitor
Start date: 2012-03-20
End date: 2012-03-20
Kalbitor
Start date: 2012-01-27
End date: 2012-01-27
Kalbitor
Start date: 2012-02-01
End date: 2012-02-01
Other drugs received by patient: Lexapro; Coreg; Insulin
Possible Cinryze side effects in female
Reported by a physician from United States on 2012-04-04
Patient: female
Reactions: Angioedema, Pulmonary Embolism, Hereditary Angioedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cinryze
Indication: Hereditary Angioedema
Start date: 2012-02-10
Kalbitor
Dosage: unknown
Indication: Hereditary Angioedema
Unspecified Allergy Injection
Dosage: unknown
Indication: Hypersensitivity
Other drugs received by patient: Apidra; Coreg; Lexapro
Possible Cinryze side effects in female
Reported by a physician from United States on 2012-04-02
Patient: female
Reactions: Angioedema, Pulmonary Embolism, Hereditary Angioedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cinryze
Indication: Hereditary Angioedema
Start date: 2012-02-10
Kalbitor
Dosage: unknown
Indication: Hereditary Angioedema
Other drugs received by patient: Lexapro; Unspecified Allergy Injection; Apidra; Coreg
Possible Cinryze side effects in female
Reported by a individual with unspecified qualification from United States on 2011-11-15
Patient: female
Reactions: Inappropriate Schedule of Drug Administration, Angioedema, Diabetes Mellitus, Hereditary Angioedema, Pulmonary Embolism, Therapy Regimen Changed
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cinryze
|